Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy.

Alves de Souza, Stephanny Miranda et al.·International journal of molecular sciences·2022·
RPEP-059822022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy.
Published In:
International journal of molecular sciences, 23(17) (2022)
Database ID:
RPEP-05982

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05982·https://rethinkpeptides.com/research/RPEP-05982

APA

Alves de Souza, Stephanny Miranda; Hernández-Ledesma, Blanca; de Souza, Theo Luiz Ferraz. (2022). Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy.. International journal of molecular sciences, 23(17). https://doi.org/10.3390/ijms23179548

MLA

Alves de Souza, Stephanny Miranda, et al. "Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy.." International journal of molecular sciences, 2022. https://doi.org/10.3390/ijms23179548

RethinkPeptides

RethinkPeptides Research Database. "Lunasin as a Promising Plant-Derived Peptide for Cancer Ther..." RPEP-05982. Retrieved from https://rethinkpeptides.com/research/alves-2022-lunasin-as-a-promising

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.